Opioid Tolerance Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

May 2019| TMR1622A| Transparency

Report Highlights

Global Opioid Tolerance Treatment Market: Overview

The global opioid tolerance treatment market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on drug, type of opioid tolerance, route of administration, end-user, and region.

A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises a competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region, thereby presenting a thorough analysis of the overall competitive scenario in the global opioid tolerance treatment market.

Global Opioid Tolerance Treatment Market: Key Segments

The opioid tolerance treatment market has been categorized based on drug, type of opioid tolerance, route of administration, end-user, and region.
In terms of drug, the global market has been segregated into NMDA antagonists, alph2-adrenoceptor agonists, and others. The NMDA antagonists segment has been sub-segmented into ketamine, dextromethorphan, and others. Similarly, the alpha2-adrenoceptor agonists segment has been divided into clonidine, tizanidine, and others.
In terms of type of opioid tolerance, the global opioid tolerance treatment market has been bifurcated into innate tolerance and acquired tolerance.
Based on route of administration, the global market has been segmented into enteral, parenteral, and others.
In terms of end-user, the global opioid tolerance treatment market has been classified into hospitals & Ambulatory surgery centers, rehabilitation centers, and others.
Each of the segments has been analyzed in detail for market trends, recent trends & developments, drivers, restraints, opportunities, and useful insights. The report provides current and future market size for each segment and sub-segments for the period from 2017 to 2027 in terms of revenue valued in US $ Mn, considering 2018 as the base year. The compound annual growth rate has been provided for each segment and market for the period of 2019 to 2027 with market size estimations.

Global Opioid Tolerance Treatment Market: Regional Outlook

In terms of region, the global opioid tolerance treatment market has been split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
These regions have been further sub-divided into major countries and sub-regions. Current and future market sizes in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report for the period from 2017 to 2027, with their CAGR (%) for the period from 2019 to 2027.
Companies Mentioned in Report

The global opioid tolerance treatment report concludes with the company profiles section that includes key information about the major players in the market. Key players identified in this report include

Boehringer Ingelheim International GmbH
GlaxoSmithKline plc.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Otsuka Pharmaceutical Co. Ltd.
Johnson & Johnson Services
Aurobindo Pharma
Pfizer Inc.
Acorda Therapeutics, Inc.
Zydus Cadila
Each of these players have been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

The global opioid tolerance treatment market has been segmented as follows:

Global Opioid Tolerance Treatment Market, by Drug
NMDA Antagonists
Ketamine
Dextromethorphan
Others (including Guaifenisin)
Alpha2-adrenoceptor Agonists
Clonidine
Tizanidne
Others(including Lofexidine)
Others (including Endothelin Receptor Antagonists, NSAIDs, Opioid Combinations, and Multimodal Pain Management Drugs)
Global Opioid Tolerance Treatment Market, by Type of Opioid Tolerance
Innate Tolerance
Acquired Tolerance
Global Opioid Tolerance Treatment Market, by Route of Administration
Enteral
Parenteral
Others (including Transdermal Route, Patches, and Cartons of Patches)
Global Opioid Tolerance Treatment Market, by End-user
Hospitals & ASCs
Rehabilitation Centers
Others (including Home Care Settings and Research Institutes)
Global Opioid Tolerance Treatment Market, by Region
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of the Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

  • Table 1 : Global Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Drug,2017-2027
  • Table 2 : Global Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Drug (NMDA Antagonists),2017-2027
  • Table 3 : Global Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Drug (Alpha2-adrenoreceptor Agonists),2017-2027
  • Table 4 : Global Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Type of Opioid Tolerance,2017-2027
  • Table 5 : Global Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Route of Administration,2017-2027
  • Table 6 : Global Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by End-user,2017-2027
  • Table 7 : Global Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Region,2017-2027
  • Table 8 : North America Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Country,2017-2027
  • Table 9 : North America Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Drug,2017-2027
  • Table 10 : North America Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Drug (NMDA Antagonists),2017-2027
  • Table 11 : North America Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Drug (Alpha2-adrenoreceptor Agonists),2017-2027
  • Table 12 : North America Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Type of Opioid Tolerance,2017-2027
  • Table 13 : North America Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Route of Administration,2017-2027
  • Table 14 : North America Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by End-user,2017-2027
  • Table 15 : Europe Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 16 : Europe Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Drug,2017-2027
  • Table 17 : Europe Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Drug (NMDA Antagonists),2017-2027
  • Table 18 : Europe Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Drug (Alpha2-adrenoceptor Agonists),2017-2027
  • Table 19 : Europe Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Type of Opioid Tolerance,2017-2027
  • Table 20 : Europe Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Route of Administration,2017-2027
  • Table 21 : Europe Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by End-user,2017-2027
  • Table 22 : Asia Pacific Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 23 : Asia Pacific Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Drug,2017-2027
  • Table 24 : Asia Pacific Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Drug (NMDA Antagonists),2017-2027
  • Table 25 : Asia Pacific Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Drug (Alpha2-adrenoceptor Agonists),2017-2027
  • Table 26 : Asia Pacific Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Type of Opioid Tolerance,2017-2027
  • Table 27 : Asia Pacific Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Route of Administration,2017-2027
  • Table 28 : Asia Pacific Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by End-user,2017-2027
  • Table 29 : Latin America Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 30 : Latin America Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Drug,2017-2027
  • Table 31 : Latin America Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Drug (NMDA Antagonists),2017-2027
  • Table 32 : Latin America Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Drug (Alpha2-adrenoceptor Agonists),2017-2027
  • Table 33 : Latin America Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Type of Opioid Tolerance,2017-2027
  • Table 34 : Latin America Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Route of Administration,2017-2027
  • Table 35 : Latin America Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by End-user,2017-2027
  • Table 36 : Middle East & Africa Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 37 : Middle East & Africa Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Drug,2017-2027
  • Table 38 : Middle East & Africa Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Drug (NMDA Antagonists),2017-2027
  • Table 39 : Middle East & Africa Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Drug (Alpha2-adrenoceptor Agonists),2017-2027
  • Table 40 : Middle East & Africa Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Type of Opioid Tolerance,2017-2027
  • Table 41 : Middle East & Africa Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by Route of Administration,2017-2027
  • Table 42 : Middle East & Africa Opioid Tolerance Treatment Market Value (US$ Mn) Forecast, by End-user,2017-2027
  • Figure 1 : Global Opioid Tolerance Treatment Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027
  • Figure 2 : Revenue Share, by Drug
  • Figure 3 : Revenue Share, by Type of Opioid Tolerance
  • Figure 4 : Revenue Share, by Route of Administration
  • Figure 5 : Revenue Share, by End-user
  • Figure 6 : Global Opioid Tolerance Treatment Market Value (US$ Mn) Forecast,2017-2027
  • Figure 7 : Global Opioid Tolerance Treatment Market Value Share, by Drug, 2018
  • Figure 8 : Global Opioid Tolerance Treatment Market Value Share, by Type of Opioid Tolerance, 2018
  • Figure 9 : Global Opioid Tolerance Treatment Market Value Share, by Route of Administration, 2018
  • Figure 10 : Global Opioid Tolerance Treatment Market Value Share, by End-user, 2018
  • Figure 11 : Global Opioid Tolerance Treatment Market Value Share, by Region, 2018
  • Figure 12 : Global Opioid Tolerance Treatment Market Value Share Analysis, by Drug, 2018 and 2027
  • Figure 13 : Global Opioid Tolerance Treatment Market Value Share Analysis, by Drug (NMDA Antagonists), 2018 and 2027
  • Figure 14 : Global Opioid Tolerance Treatment Market Value Share Analysis, by Drug (Alpha2-adrenoreceptor Agonists), 2018 and 2027
  • Figure 15 : Global Opioid Tolerance Treatment Market Revenue (US$ Mn), by NMDA Antagonists,2017-2027
  • Figure 16 : Global Opioid Tolerance Treatment Market Revenue (US$ Mn), by Alpha2-adrenoceptor Agonists,2017-2027
  • Figure 17 : Global Opioid Tolerance Treatment Market Revenue (US$ Mn), by Others,2017-2027
  • Figure 18 : Global Opioid Tolerance Treatment Market Attractiveness Analysis, by Drug,2017-2027
  • Figure 19 : Global Opioid Tolerance Treatment Market Value Share Analysis, by Type of Opioid Tolerance, 2018 and 2027
  • Figure 20 : Global Opioid Tolerance Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Innate Tolerance,2017-2027
  • Figure 21 : Global Opioid Tolerance Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Acquired Tolerance,2017-2027
  • Figure 22 : Opioid Tolerance Treatment Market Attractiveness Analysis, by Type of Opioid Tolerance, 2019–2027
  • Figure 23 : Global Opioid Tolerance Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 24 : Global Opioid Tolerance Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Enteral,2017-2027
  • Figure 25 : Global Opioid Tolerance Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Parenteral,2017-2027
  • Figure 26 : Global Opioid Tolerance Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others,2017-2027
  • Figure 27 : Opioid Tolerance Treatment Market Attractiveness Analysis, by Route of Administration
  • Figure 28 : Global Opioid Tolerance Treatment Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 29 : Global Opioid Tolerance Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals & ASCs,2017-2027
  • Figure 30 : Global Opioid Tolerance Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Rehabilitation Centers,2017-2027
  • Figure 31 : Global Opioid Tolerance Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others,2017-2027
  • Figure 32 : Opioid Tolerance Treatment Market Attractiveness Analysis, by End-user
  • Figure 33 : Global Opioid Tolerance Treatment Market Value Share, by Region, 2018 and 2027
  • Figure 34 : Global Opioid Tolerance Treatment Market Attractiveness Analysis, by Region, 2019–2027
  • Figure 35 : North America Opioid Tolerance Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%),2017-2027
  • Figure 36 : North America Opioid Tolerance Treatment Market Value Share, by Country, 2018 and 2027
  • Figure 37 : North America Opioid Tolerance Treatment Market Attractiveness, by Country, 2019–2027
  • Figure 38 : North America Opioid Tolerance Treatment Market Value Share, by Drug, 2018 and 2027
  • Figure 39 : North America Opioid Tolerance Treatment Market Attractiveness, by Drug, 2019–2027
  • Figure 40 : North America Opioid Tolerance Treatment Market Value Share Analysis, by Drug (NMDA Antagonists), 2018 and 2027
  • Figure 41 : North America Opioid Tolerance Treatment Market Value Share Analysis, by Drug (Alpha2-adrenoceptor Agonists), 2018 and 2027
  • Figure 42 : North America Opioid Tolerance Treatment Market Value Share, by Type of Opioid Tolerance, 2018 and 2027
  • Figure 43 : North America Opioid Tolerance Treatment Market Attractiveness, by Type of Opioid Tolerance, 2019–2027
  • Figure 44 : North America Opioid Tolerance Treatment Market Value Share, by Route of Administration, 2018 and 2027
  • Figure 45 : North America Opioid Tolerance Treatment Market Attractiveness, by Route of Administration, 2019–2027
  • Figure 46 : North America Opioid Tolerance Treatment Market Value Share, by End-user, 2018 and 2027
  • Figure 47 : North America Opioid Tolerance Treatment Market Attractiveness, by End-user, 2019–2027
  • Figure 48 : Europe Opioid Tolerance Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%),2017-2027
  • Figure 49 : Europe Opioid Tolerance Treatment Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 50 : Europe Opioid Tolerance Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
  • Figure 51 : Europe Opioid Tolerance Treatment Market Value Share, by Drug, 2018 and 2027
  • Figure 52 : Europe Opioid Tolerance Treatment Market Attractiveness, by Drug, 2019–2027
  • Figure 53 : Europe Opioid Tolerance Treatment Market Value Share Analysis, by Drug (NMDA Antagonists), 2018 and 2027
  • Figure 54 : Europe Opioid Tolerance Treatment Market Value Share Analysis, by Drug (Alpha2-adrenoceptor Agonists), 2018 and 2027
  • Figure 55 : Europe Opioid Tolerance Treatment Market Value Share, by Type of Opioid Tolerance, 2018 and 2027
  • Figure 56 : Europe Opioid Tolerance Treatment Market Attractiveness, by Type of Opioid Tolerance, 2019–2027
  • Figure 57 : Europe Opioid Tolerance Treatment Market Value Share, by Route of Administration, 2018 and 2027
  • Figure 58 : Europe Opioid Tolerance Treatment Market Attractiveness, by Route of Administration, 2019–2027
  • Figure 59 : Europe Opioid Tolerance Treatment Market Value Share, by End-user, 2018 and 2027
  • Figure 60 : Europe Opioid Tolerance Treatment Market Attractiveness, by End-user, 2019–2027
  • Figure 61 : Asia Pacific Opioid Tolerance Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%),2017-2027
  • Figure 62 : Asia Pacific Opioid Tolerance Treatment Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 63 : Asia Pacific Opioid Tolerance Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
  • Figure 64 : Asia Pacific Opioid Tolerance Treatment Market Value Share, by Drug, 2018 and 2027
  • Figure 65 : Asia Pacific Opioid Tolerance Treatment Market Attractiveness, by Drug, 2019–2027
  • Figure 66 : Asia Pacific Opioid Tolerance Treatment Market Value Share Analysis, by Drug (NMDA Antagonists), 2018 and 2027
  • Figure 67 : Asia Pacific Opioid Tolerance Treatment Market Value Share Analysis, by Drug (Alpha2-adrenoceptor Agonists), 2018 and 2027
  • Figure 68 : Asia Pacific Opioid Tolerance Treatment Market Value Share, by Type of Opioid Tolerance, 2018 and 2027
  • Figure 69 : Asia Pacific Opioid Tolerance Treatment Market Attractiveness, by Type of Opioid Tolerance, 2019–2027
  • Figure 70 : Asia Pacific Opioid Tolerance Treatment Market Value Share, by Route of Administration, 2018 and 2027
  • Figure 71 : Asia Pacific Opioid Tolerance Treatment Market Attractiveness, by Route of Administration, 2019–2027
  • Figure 72 : Asia Pacific Opioid Tolerance Treatment Market Value Share, by End-user, 2018 and 2027
  • Figure 73 : Asia Pacific Opioid Tolerance Treatment Market Attractiveness, by End-user, 2019–2027
  • Figure 74 : Latin America Opioid Tolerance Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%),2017-2027
  • Figure 75 : Latin America Opioid Tolerance Treatment Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 76 : Latin America Opioid Tolerance Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
  • Figure 77 : Latin America Opioid Tolerance Treatment Market Value Share, by Drug, 2018 and 2027
  • Figure 78 : Latin America Opioid Tolerance Treatment Market Attractiveness, by Drug, 2019–2027
  • Figure 79 : Latin America Opioid Tolerance Treatment Market Value Share Analysis, by Drug (NMDA Antagonists), 2018 and 2027
  • Figure 80 : Latin America Opioid Tolerance Treatment Market Value Share Analysis, by Drug (Alpha2-adrenoceptor Agonists), 2018 and 2027
  • Figure 81 : Latin America Opioid Tolerance Treatment Market Value Share, by Type of Opioid Tolerance, 2018 and 2027
  • Figure 82 : Latin America Opioid Tolerance Treatment Market Attractiveness, by Type of Opioid Tolerance, 2019–2027
  • Figure 83 : Latin America Opioid Tolerance Treatment Market Value Share, by Route of Administration, 2018 and 2027
  • Figure 84 : Latin America Opioid Tolerance Treatment Market Attractiveness, by Route of Administration, 2019–2027
  • Figure 85 : Latin America Opioid Tolerance Treatment Market Value Share, by End-user, 2018 and 2027
  • Figure 86 : Latin America Opioid Tolerance Treatment Market Attractiveness, by End-user, 2019–2027
  • Figure 87 : Middle East & Africa Opioid Tolerance Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%),2017-2027
  • Figure 88 : Middle East & Africa Opioid Tolerance Treatment Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 89 : Middle East & Africa Opioid Tolerance Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
  • Figure 90 : Middle East & Africa Opioid Tolerance Treatment Market Value Share, by Drug, 2018 and 2027
  • Figure 91 : Middle East & Africa Opioid Tolerance Treatment Market Attractiveness, by Drug, 2019–2027
  • Figure 92 : Middle East & Africa Opioid Tolerance Treatment Market Value Share Analysis, by Drug (NMDA Antagonists), 2018 and 2027
  • Figure 93 : Middle East & Africa Opioid Tolerance Treatment Market Value Share Analysis, by Drug (Alpha2-adrenoceptor Agonists), 2018 and 2027
  • Figure 94 : Middle East & Africa Opioid Tolerance Treatment Market Value Share, by Type of Opioid Tolerance, 2018 and 2027
  • Figure 95 : Middle East & Africa Opioid Tolerance Treatment Market Attractiveness, by Type of Opioid Tolerance, 2019–2027
  • Figure 96 : Middle East & Africa Opioid Tolerance Treatment Market Value Share, by Route of Administration, 2018 and 2027
  • Figure 97 : Middle East & Africa Opioid Tolerance Treatment Market Attractiveness, by Route of Administration, 2019–2027
  • Figure 98 : Middle East & Africa Opioid Tolerance Treatment Market Value Share, by End-user, 2018 and 2027
  • Figure 99 : Middle East & Africa Opioid Tolerance Treatment Market Attractiveness, by End-user, 2019–2027

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report